(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid

C72H86N24O10 — CID 165028597

IUPAC(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid
SMILESCOc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)O.C[C@H](CO)n1nnnc1-c1cccc(N)n1
InChIInChI=1S/2C24H28N8O3.C15H18N2O3.C9H12N6O/c2*1-14(2)31-10-9-19(28-31)17-12-18(21(35-5)11-15(17)3)24(34)26-22-8-6-7-20(25-22)23-27-29-30-32(23)16(4)13-33;1-9(2)17-6-5-13(16-17)11-8-12(15(18)19)14(20-4)7-10(11)3;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-12,14,16,33H,13H2,1-5H3,(H,25,26,34);5-9H,1-4H3,(H,18,19);2-4,6,16H,5H2,1H3,(H2,10,11)/t2*16-;;6-/m11.1/s1
InChIKeyMHAFTOPLLCQRGX-NFSNNPESSA-N
MW1447.64 g/mol
LogP9.62
Rot. Bonds23

About (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid

(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid (PubChem CID 165028597) has the molecular formula C72H86N24O10 and a molecular weight of 1447.64 g/mol. Its IUPAC name is (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid.

Molecular Properties

Compound Name(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid
PubChem CID165028597
Molecular FormulaC72H86N24O10
Molecular Weight1447.64 g/mol
Exact Mass1446.70
IUPAC Name(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid
SMILESCOc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)O.C[C@H](CO)n1nnnc1-c1cccc(N)n1
InChIInChI=1S/2C24H28N8O3.C15H18N2O3.C9H12N6O/c2*1-14(2)31-10-9-19(28-31)17-12-18(21(35-5)11-15(17)3)24(34)26-22-8-6-7-20(25-22)23-27-29-30-32(23)16(4)13-33;1-9(2)17-6-5-13(16-17)11-8-12(15(18)19)14(20-4)7-10(11)3;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-12,14,16,33H,13H2,1-5H3,(H,25,26,34);5-9H,1-4H3,(H,18,19);2-4,6,16H,5H2,1H3,(H2,10,11)/t2*16-;;6-/m11.1/s1
InChIKeyMHAFTOPLLCQRGX-NFSNNPESSA-N
XLogP9.62
TPSA432.83 Ų
H-Bond Donors7
H-Bond Acceptors31
Rotatable Bonds23
Heavy Atoms106
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001447.64
LogP ≤ 59.62
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1031

Analyze (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid?
The IUPAC name of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid (CID 165028597) is (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid.
What is the SMILES notation for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid?
The canonical SMILES for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid is COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)Nc1cccc(-c2nnnn2[C@H](C)CO)n1.COc1cc(C)c(-c2ccn(C(C)C)n2)cc1C(=O)O.C[C@H](CO)n1nnnc1-c1cccc(N)n1.
What is the InChIKey of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid?
The InChIKey is MHAFTOPLLCQRGX-NFSNNPESSA-N. The full InChI is InChI=1S/2C24H28N8O3.C15H18N2O3.C9H12N6O/c2*1-14(2)31-10-9-19(28-31)17-12-18(21(35-5)11-15(17)3)24(34)26-22-8-6-7-20(25-22)23-27-29-30-32(23)16(4)13-33;1-9(2)17-6-5-13(16-17)11-8-12(15(18)19)14(20-4)7-10(11)3;1-6(5-16)15-9(12-13-14-15)7-3-2-4-8(10)11-7/h2*6-12,14,16,33H,13H2,1-5H3,(H,25,26,34);5-9H,1-4H3,(H,18,19);2-4,6,16H,5H2,1H3,(H2,10,11)/t2*16-;;6-/m11.1/s1.
What are the key properties of (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid?
(2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid has a molecular weight of 1447.64 g/mol, XLogP of 9.62, 23 rotatable bonds, 7 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[5-(6-amino-2-pyridinyl)tetrazol-1-yl]propan-1-ol;bis(N-[6-[1-[(2R)-1-hydroxypropan-2-yl]tetrazol-5-yl]-2-pyridinyl]-2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzamide);2-methoxy-4-methyl-5-(1-propan-2-ylpyrazol-3-yl)benzoic acid is sourced from PubChem (CID 165028597), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).